Synthesis of Azido-Globo H Analogs for Immunogenicity Evaluation
Chiang-Yun Chen,Yu-Wei Lin,Szu-Wen Wang,Yung-Chu Lin,Yang-Yu Cheng,Chien-Tai Ren,Chi-Huey Wong,Chung-Yi Wu
DOI: https://doi.org/10.1021/acscentsci.1c01277
IF: 18.2
2021-12-21
ACS Central Science
Abstract:Globo H (GH) is a tumor-associated carbohydrate antigen (TACA), and GH conjugations have been evaluated as potential cancer vaccines. However, like all carbohydrate-based vaccines, low immunogenicity is a major issue. Modifications of the TACA increase its immunogenicity, but the systemic modification on GH is challenging and the synthesis is cumbersome. In this study, we synthesized several azido-GH analogs for evaluation, using galactose oxidase to selectively oxidize C6-OH of the terminal galactose or <i>N</i>-acetylgalactosamine on lactose, Gb3, Gb4, and SSEA3 into C6 aldehyde, which was then transformed chemically to the azido group. The azido-derivatives were further glycosylated to azido-GH analogs by glycosyltransferases coupled with sugar nucleotide regeneration. These azido-GH analogs and native GH were conjugated to diphtheria toxoid cross-reactive material CRM197 for vaccination with C34 adjuvant in mice. Glycan array analysis of antisera indicated that the azido-GH glycoconjugate with azide at Gal-C6 of Lac (<b>1-CRM197</b>) elicited the highest antibody response not only to GH, SSEA3, and SSEA4, which share the common SSEA3 epitope, but also to MCF-7 cancer cells, which express these Globo-series glycans.
chemistry, multidisciplinary